Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $127.91 USD
Change Today +2.65 / 2.12%
Volume 2.2M
TMO On Other Exchanges
New York
As of 8:04 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

thermo fisher scientific inc (TMO) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/15 - $141.25
52 Week Low
10/15/14 - $107.33
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

thermo fisher scientific inc (TMO) Details

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. It serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as the clinical laboratory. The company’s Specialty Diagnostics segment offers liquid, ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratory customers. Its Laboratory Products and Services segment offers sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, water analysis instruments, and other laboratory equipment, as well as laboratory consumables, research and safety market solutions, and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

51,000 Employees
Last Reported Date: 03/5/15
Founded in 1956

thermo fisher scientific inc (TMO) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $1.3M
Executive Vice President and President of Lif...
Total Annual Compensation: $723.1K
Executive Vice President and President of Lab...
Total Annual Compensation: $716.2K
Senior Vice President and President of Analyt...
Total Annual Compensation: $568.1K
Chief Administrative Officer, Senior Vice Pre...
Total Annual Compensation: $674.0K
Compensation as of Fiscal Year 2014.

thermo fisher scientific inc (TMO) Key Developments

Instrumentation Laboratory Announces Distributor Agreement with Thermo Fisher Scientific for Hemostasis Lab Automation System

Instrumentation Laboratory Company (IL) announced they have signed an International Distribution Agreement with Thermo Fisher Scientific appointing IL as the exclusive worldwide distributor for the Thermo Scientific TCAutomation Laboratory Automation System (LAS) in the field of Hemostasis. IL will offer ‘Hemostasis Lab Automation Work Cell’ solutions, comprised of their ACL TOP 700/750 LAS Hemostasis Testing Systems, integrated with the TCAutomation LAS. Hemostasis labs considering automation to standardize their testing processes and help manage heavy workloads can now rely on the Hemostasis expertise of IL, Hemostasis diagnostics, coupled with the automation expertise of Thermo Fisher, to provide them with tailored automated solutions. Designed to offer laboratories a truly efficient workflow through modularity, flexibility and connectivity, Thermo Scientific TCAutomation system helps manage the increasing workloads and improve quality. Interfacing ACL TOP 700/750 LAS Hemostasis Testing Systems with TCAutomation system and automating the key pre- and post-analytical steps, such as decapping, centrifugation, aliquoting, sorting, storing and recapping, introduces a compact automation Work Cell solution for Hemostasis testing.

Thermo Fisher Scientific, Inc. Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:30 AM

Thermo Fisher Scientific, Inc. Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:30 AM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: Mark P. Stevenson, Executive Vice President and President of Life Sciences Solutions.

Thermo Fisher Scientific Unveils New Solutions to Advance the Use of Clinical Testing and Improve Patient Outcomes

Thermo Fisher Scientific, Inc. introduced new instruments and assays to expand the use of clinical testing, enhance laboratory productivity and ultimately improve patient outcomes. The new solutions were unveiled at the 2015 AACC Annual Meeting and Clinical Lab Expo, Booth 3135, being held at the Georgia World Congress Center in Atlanta, July 26 - 30. For laboratories performing allergy and autoimmunity testing, the fully automated Thermo Scientific Phadia 2500E Laboratory System analyzes up to 25,000 samples per week, enabling clinical labs to deliver patient test results quickly and accurately. These Phadia Laboratory Systems detect and quantify relevant antibodies in blood samples to identify possible allergy or autoimmune sensitivity. The company’s portfolio of allergy test kits has been expanded to include ImmunoCAP Allergen Components for Hazelnut, Walnut and Cashew Nut to better identify patients who may have potentially serious reactions to a wider variety of food products. Thermo Fisher has also introduced new immunoassays with FDA 510(k) clearance for the detection of autoimmune disorders. These include the EliA PR3, EliA MPO and EliA GBM Assays, which measure auto-antibodies for the diagnosis of ANCA Vasculitis, Goodpasture Syndrome and associated conditions that typically result in kidney disease. All of these conditions exhibit very similar symptoms, and the new tests allow for a specific diagnosis, allowing clinicians to develop a better-informed patient treatment strategy.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMO:US $127.91 USD +2.65

TMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $45.64 USD +1.66
Danaher Corp $88.46 USD +1.79
General Dynamics Corp $145.17 USD +1.12
Safran SA €66.41 EUR -0.85
Syngenta AG SFr.322.40 CHF -2.80
View Industry Companies

Industry Analysis


Industry Average

Valuation TMO Industry Range
Price/Earnings 25.6x
Price/Sales 3.0x
Price/Book 2.4x
Price/Cash Flow 25.3x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERMO FISHER SCIENTIFIC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at